Last reviewed · How we verify
NCT05575102
Walking Football for People With Chronic Breathlessness
NA trial testing Walking Football in Dyspnea in 6 participants. Completed in 13 December 2023.
29 June 2023
Quick facts
| Lead sponsor | Teesside University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 22 March 2023 |
| Primary completion | 29 June 2023 |
| Estimated completion | 13 December 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Walking Football
Conditions studied
- Dyspnea — all drugs for Dyspnea →
Sponsor
Teesside University
Who can join
35 and older, any sex, with Dyspnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the feasibility of a walking football intervention for people with chronic breathlessness. Chronic breathlessness refers to breathlessness that persists despite optimal treatment of the underlying pathophysiology. Roughly 9-13% of the general population will experience chronic breathlessness, with incidence rising with age to 37% for those aged over 60years. This mixed-methods study will offer patients who have enrolled on to pulmonary rehabilitation (PR) the prospect to partake in walking football once they have completed their scheduled programmes (or voluntarily dropped-out); introducing a potential opportunity for long-term exercise maintenance post PR. Participants will be recruited from North Tees \& Hartlepool Foundation Trust, and South Tees Foundation Trust. PR is recommended for all people with chronic breathlessness and has been shown to improve exercise capacity and health-related quality of life. However, PR programmes typically only last for 6-12 weeks, and have little to no impact on long-term physical activity levels. Walking Football has been identified as a potential form of exercise which people with breathlessness could maintain post-PR, thus offering a solution to PRs limited ability to promote exercise maintenance. Participants will be invited to play walking football for 6-weeks (2-hours weekly) in the Middlesbrough/Stockton area. Before and after weeks 1 and 6, breathlessness-relevant outcomes will be measured including; exercise capacity, lower-limb strength, perceived breathlessness, quality of life, balance confidence, depression, and anxiety. During a participant's third session, one-time physical intensity outcomes will be calculated during play including heart-rate and perceived intensity. Participants will also be invited to an interview to discuss how feasible they have found the football, any benefits they may have experienced, and how the football programme could be improved. The study will officially end with a co-production workshop; a focus group with stakeholders (players, physiotherapists, co-ordinators, researchers) after preliminary analysis has been conducted to discuss initial findings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05575102
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Walking Football
Trials testing the same drug.
- NCT07414823 — Walking Football for Axial Spondyloarthritis · NA · active not recruiting
Other recruiting trials for Dyspnea
Currently open trials in the same condition.
- NCT07386444 — Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy · NA · recruiting
- NCT06807983 — LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly · NA · recruiting
- NCT07104578 — Evaluation of the Impact of Pleuropulmonary Ultrasound on the Diagnosis of Dyspnea · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06556797 — Proof-of-concept Study on Dyspnea Analysis Via GapCO2 · recruiting
Other Teesside University trials
Trials by the same sponsor.
- NCT07510230 — Media Orientation to Improve Childhood Vaccine Uptake and Address Parent and Caregivers Vaccine-related Anxiety: A Pilot · NA · not yet recruiting
- NCT07251478 — Transparent Communication to Improve Mental Wellbeing and Attitude Towards Reintegration · NA · not yet recruiting
- NCT06998602 — Student Paramedics' Experiences of Compassion Fatigue: a Phenomenological Mixed-methods Study · completed
- NCT06628518 — FAmily Oriented Mindfulness Informed Legal Education (FAMiLE) Programme for Parent or Carers Affected by Incarceration a · NA · not yet recruiting
- NCT06601023 — Problem Management Plus Mindfulness-informed Legal Education for Addressing Gender-based Violence and Improving Parentin · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05575102 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Teesside University
- Last refreshed: 10 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05575102.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing